Hypertension Management in Elderly Patients

Initial Treatment and Dose Titration

The European Society of Cardiology recommends that initial doses and subsequent dose titration should be more gradual in elderly patients because of a greater chance of undesirable effects, especially in very old and frail subjects 1.
Elderly patients need slower titration to minimize adverse effects, particularly orthostatic hypotension, as emphasized by the European Society of Cardiology 1, 2.
Blood pressure should always be measured in both sitting and standing positions in elderly patients due to increased risk of postural hypotension 1, 2.

For patients aged ≥60 years, guidelines recommend initiating treatment when BP is ≥150/90 mmHg 5.
Target blood pressure is <140/90 mmHg for most elderly patients, if tolerated, as recommended by the European Society of Cardiology and other guidelines 1, 2, 5.
The 2024 ESC guidelines recommend targeting systolic BP 120-129 mmHg in most adults if well tolerated, but acknowledge that achieving targets "as low as reasonably achievable" (ALARA principle) is acceptable when lower targets are poorly tolerated 4.

If blood pressure remains uncontrolled, consider adding a calcium channel blocker (preferably amlodipine) as the third agent, with the preferred three-drug combination being RAS blocker + CCB + thiazide diuretic 3, 4.
The American Heart Association and European Society of Cardiology recommend a gradual approach to treatment escalation, with regular monitoring of blood pressure and adverse effects 1, 4.

Never start at maximum dose in elderly patients, as this increases risk of symptomatic hypotension, falls, and electrolyte disturbances 1, 2.
Elderly patients are at high risk for postural hypotension, and orthostatic vital signs should be checked regularly 1, 2.